✅ Great for Annual Maintenance!
Access Insight
Clarity after launch. Confidence in prescribing visibility.
What is Access Insight?
Access Insight is our focused visibility review service, designed for pharmaceutical and digital health companies who’ve already launched — but need to understand exactly how their product is appearing in front of health care professionals in primary care.
We compile a report with a clear, evidence-based picture of how your product is listed across key NHS prescribing infrastructure — so you can identify issues, support your field teams, and optimise market access.
Who is it for?
Access Insight is built for teams who need certainty that their product is visible, aligned, and prescribable across the systems used in UK primary care.
If you’ve ever asked:
“Is our product actually showing up in clinical systems?”
“Why are GPs saying they can’t find it?”
“Has it gone live in the Drug Tariff yet?”
“Do we have screenshots to confirm visibility?”
…then Access Insight is for you.
Why and When to use Access Insight?
Even after launch, products can face hidden visibility issues — misaligned codes, delayed listings, or system changes that go unnoticed. If your product isn’t listed correctly, it won’t be prescribed.
Access Insight helps you catch and correct these issues early — and maintain confidence in your market access strategy.
We recommend using this service:
• 6 months post-launch to confirm visibility across systems
• Any time prescribing uptake is lower than expected
• When field teams report access issues or GP feedback
• As an annual check-up to ensure ongoing alignment with system and guidance updates
Features.
A clear, post-launch system visibility review with everything you need to assess, align, and act.
Ready to see how your product appears in the real world?
Book a quick intro call with our team below
